Ethereum sits at a crossroads as traders debate whether the second-largest cryptocurrency will finally break through $3,000 or plunge back down to $2,000.
AlphaGenome, accessible via API, cracks the “junk DNA” code, outperforms top rivals in key tests, and puts advanced genomics tools within reach of labs around the world.